Is Heart Test Stock a Good Investment?
Heart Test Investment Advice | HSCSW |
Not Rated
Examine Heart Test Stock
Researching Heart Test's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). The company recorded a loss per share of 1.09. Heart Test Laboratories had not issued any dividends in recent years. The entity had 1:100 split on the 17th of May 2024.
To determine if Heart Test is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Heart Test's research are outlined below:
| Heart Test is not yet fully synchronised with the market data | |
| Heart Test is way too risky over 90 days horizon | |
| Heart Test has some characteristics of a very speculative penny stock | |
| Heart Test appears to be risky and price may revert if volatility continues | |
| Heart Test has high likelihood to experience some financial distress in the next 2 years | |
| Heart Test Laboratories has accumulated 1.04 M in total debt. Heart Test Laboratories has a current ratio of 0.58, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Note, when we think about Heart Test's use of debt, we should always consider it together with its cash and equity. | |
| The entity reported the revenue of 18.6 K. Net Loss for the year was (6.61 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Heart Test Laboratories has accumulated about 723.48 K in cash with (6.07 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.22, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Heart Test has a poor financial position based on the latest SEC disclosures |
Heart Test's profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.83) | (0.88) | |
| Return On Capital Employed | (0.81) | (0.85) | |
| Return On Assets | (0.70) | (0.73) | |
| Return On Equity | (0.90) | (0.95) |
Determining Heart Test's profitability involves analyzing its financial statements and using various financial metrics to determine if Heart Test is a good buy. For example, gross profit margin measures Heart Test's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Heart Test's profitability and make more informed investment decisions.
Please note, the imprecision that can be found in Heart Test's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Heart Test Laboratories. Check Heart Test's Beneish M Score to see the likelihood of Heart Test's management manipulating its earnings.
Evaluate Heart Test's management efficiency
The company has return on total asset (ROA) of (0.8169) % which means that it has lost $0.8169 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (2.6929) %, meaning that it generated substantial loss on money invested by shareholders. Heart Test's management efficiency ratios could be used to measure how well Heart Test manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.88 in 2024. Return On Capital Employed is likely to drop to -0.85 in 2024. At this time, Heart Test's Total Assets are fairly stable compared to the past year. Non Current Assets Total is likely to climb to about 2.3 M in 2024, whereas Intangible Assets are likely to drop slightly above 1.3 M in 2024.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 20.76 | 21.79 | |
| Tangible Book Value Per Share | 16.25 | 17.06 | |
| Enterprise Value Over EBITDA | 0.25 | 0.26 | |
| Price Book Value Ratio | 0.45 | 0.42 | |
| Enterprise Value Multiple | 0.25 | 0.26 | |
| Price Fair Value | 0.45 | 0.42 | |
| Enterprise Value | -1.5 M | -1.4 M |
Leadership at Heart Test emphasizes sustainable growth and financial prudence. Our analysis evaluates how these priorities impact the stock's performance in the market.
Beta 3.294 |
Understand Heart Test's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Heart Test's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | 0.0988 | |||
| Market Risk Adjusted Performance | (1.62) | |||
| Mean Deviation | 19.25 | |||
| Semi Deviation | 16.89 | |||
| Downside Deviation | 25.86 | |||
| Coefficient Of Variation | 860.85 | |||
| Standard Deviation | 30.17 | |||
| Variance | 910.18 | |||
| Information Ratio | 0.1118 | |||
| Jensen Alpha | 3.75 | |||
| Total Risk Alpha | (1.26) | |||
| Sortino Ratio | 0.1304 | |||
| Treynor Ratio | (1.63) | |||
| Maximum Drawdown | 150.0 | |||
| Value At Risk | (42.69) | |||
| Potential Upside | 78.0 | |||
| Downside Variance | 668.98 | |||
| Semi Variance | 285.16 | |||
| Expected Short fall | (40.50) | |||
| Skewness | 1.3 | |||
| Kurtosis | 2.38 |
| Risk Adjusted Performance | 0.0988 | |||
| Market Risk Adjusted Performance | (1.62) | |||
| Mean Deviation | 19.25 | |||
| Semi Deviation | 16.89 | |||
| Downside Deviation | 25.86 | |||
| Coefficient Of Variation | 860.85 | |||
| Standard Deviation | 30.17 | |||
| Variance | 910.18 | |||
| Information Ratio | 0.1118 | |||
| Jensen Alpha | 3.75 | |||
| Total Risk Alpha | (1.26) | |||
| Sortino Ratio | 0.1304 | |||
| Treynor Ratio | (1.63) | |||
| Maximum Drawdown | 150.0 | |||
| Value At Risk | (42.69) | |||
| Potential Upside | 78.0 | |||
| Downside Variance | 668.98 | |||
| Semi Variance | 285.16 | |||
| Expected Short fall | (40.50) | |||
| Skewness | 1.3 | |||
| Kurtosis | 2.38 |
Consider Heart Test's intraday indicators
Heart Test intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Heart Test stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 0.0301 | |||
| Day Typical Price | 0.0301 | |||
| Relative Strength Index | 33.87 |
Heart Stock media impact
Far too much social signal, news, headlines, and media speculation about Heart Test that are available to investors today. That information is available publicly through Heart media outlets and privately through word of mouth or via Heart internal channels. However, regardless of the origin, that massive amount of Heart data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Heart Test news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Heart Test relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Heart Test's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Heart Test alpha.
Heart Test Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Heart Test can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Heart Test Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Heart Test stock to make a market-neutral strategy. Peer analysis of Heart Test could also be used in its relative valuation, which is a method of valuing Heart Test by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Heart Test Corporate Executives
Elected by the shareholders, the Heart Test's board of directors comprises two types of representatives: Heart Test inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Heart. The board's role is to monitor Heart Test's management team and ensure that shareholders' interests are well served. Heart Test's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Heart Test's outside directors are responsible for providing unbiased perspectives on the board's policies.
Additional Tools for Heart Stock Analysis
When running Heart Test's price analysis, check to measure Heart Test's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Heart Test is operating at the current time. Most of Heart Test's value examination focuses on studying past and present price action to predict the probability of Heart Test's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Heart Test's price. Additionally, you may evaluate how the addition of Heart Test to your portfolios can decrease your overall portfolio volatility.